Market Snapshot

BSE Sensex: 75527.95 2.30%
BSE 500: 35342.5 2.20%
BSE 200: 11009.02 2.14%
BSE 100: 25089.37 2.11%
BSE BANKEX: 63987.8 2.94%
BSE IT: 27167.9 0.39%
Nifty 50: 23622.9 1.99%
Nifty 500: 22599.8 2.19%
Nifty 200: 13618.55 2.14%
Nifty 100: 24602.25 2.06%
Nifty Midcap 100: 60768.1 2.43%
Nifty Small 100: 18197.45 2.80%
Nifty IT: 27795.75 -0.09%
Nifty PSU Bank: 8528.75 2.71%

News:

RBL Bank appoints Bhavin Lakhp...
BHEL bags over Rs 90-cr LNTP f...
Fractal Analytics ends higher ...
Mahindra EPC Irrigation bags R...
DOMS Inds surges after inking ...

Kilitch Drugs (India) Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

12 Jun 2026 | 03:59 PM

188.40

7.35 (4.06%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-17.01%

Return (1Y)

Underperformed BSE Sensex by 9.46%
More Volatile

2.88%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.05%
Not so consistent

6/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

245

121

News & Announcements

Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter

28 days ago

Kilitch Drugs (India) to conduct board meeting
37 days ago

Kilitch Drugs (India) to conduct board meeting

07 - May - 2026 12:00 | 37 days ago

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 15 May 2026.
Kilitch Drugs (India) schedules EGM
119 days ago

Kilitch Drugs (India) schedules EGM

14 - Feb - 2026 12:00 | 119 days ago

Kilitch Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 13 March 2026.
Powered by Capital Market - Live News
Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter
121 days ago

Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter

12 - Feb - 2026 12:00 | 121 days ago

Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 53.81 56.17 -4

OPM % 11.43 15.54 -

PBDT 6.53 9.06 -28

PBT 5.60 8.25 -32

NP 4.43 5.96 -26

Powered by Capital Market - Live News

Stock Trivia

Promoter shareholding in Kilitch Drugs (India) Ltd has decreased by -7.88% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60